RILUTEK TABLET 50 mg Singapore - English - HSA (Health Sciences Authority)

rilutek tablet 50 mg

sanofi-aventis singapore pte. ltd. - riluzole - tablet, film coated - 50 mg - riluzole 50 mg

Zaltrap New Zealand - English - Medsafe (Medicines Safety Authority)

zaltrap

sanofi-aventis new zealand limited - aflibercept 25 mg/ml;   - concentrate for infusion - 25 mg/ml - active: aflibercept 25 mg/ml   excipient: citric acid dibasic sodium phosphate heptahydrate hydrochloric acid monobasic sodium phosphate monohydrate polysorbate 20 sodium chloride sodium citrate dihydrate sodium hydroxide sucrose water for injection - zaltrap in combination with irinotecan-fluoropyrimidine-based chemotherapy is indicated in adults with metastatic colorectal cancer previously treated with an oxaliplatin-containing regimen.

Zaltrap New Zealand - English - Medsafe (Medicines Safety Authority)

zaltrap

sanofi-aventis new zealand limited - aflibercept 25 mg/ml;   - concentrate for infusion - 25 mg/ml - active: aflibercept 25 mg/ml   excipient: citric acid dibasic sodium phosphate heptahydrate hydrochloric acid monobasic sodium phosphate monohydrate polysorbate 20 sodium chloride sodium citrate dihydrate sodium hydroxide sucrose water for injection - zaltrap in combination with irinotecan-fluoropyrimidine-based chemotherapy is indicated in adults with metastatic colorectal cancer previously treated with an oxaliplatin-containing regimen.